Specify a stock or a cryptocurrency in the search bar to get a summary
Polarean Imaging Plc
PLLWFPolarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas polariser devices in Canada, the United Kingdom, and the United States. It engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. The company also offers XENOVIEW, a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older; and measurement station, chest coil, and dose delivery inhalation bags. Polarean Imaging plc was incorporated in 2016 and is based in London, the United Kingdom. Address: 27-28 Eastcastle Street, London, United Kingdom, W1W 8DH
Analytics
WallStreet Target Price
609.2 GBXP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures PLLWF
Dividend Analytics PLLWF
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PLLWF
Stock Valuation PLLWF
Financials PLLWF
Results | 2019 | Dynamics |